OCA - Oceania Healthcare

Started by Benji, Jun 24, 2022, 03:46 PM

Previous topic - Next topic

0 Members and 0 Guests are viewing this topic.

winner (n)

Quote from: Shareguy on May 01, 2025, 04:41 PMWas looking at the Helier last year for a family member. Family member had a friend already there who said it was "a ghost town"

Today had a call from Oceania to say now 30 residents reside. Does not seem like a lot.

Said 34 in half year to September

Basil

Sales should only be reported as such when they're unconditional and a proper 10% deposit is received, in my opinion.  Even then a sale can fall over if the incoming resident can't sell their home.   Just out of curiosity, what methodology do OCA use to record something as being "sold".

Greekwatchdog

All will be revealed in 21 days..

winner (n)

Quote from: Basil on May 01, 2025, 06:14 PMSales should only be reported as such when they're unconditional and a proper 10% deposit is received, in my opinion.  Even then a sale can fall over if the incoming resident can't sell their home.   Just out of curiosity, what methodology do OCA use to record something as being "sold".

Goodness knows when a unit is 'sold' ...seems to change quite often

Whatever last March they had the best part of $100m in receivables from oRA.s ...no doubt 'sold' still to be paid for (in full)

Basil

#1729
That's a heck lot of receivables eh.  Well over 100 properties at OCA's average asking price.  What's the bet some of these sales are just a few thousand dollars down and the incoming resident uses best efforts to sell their home to afford the rest and a fair few of them are struggling to sell their homes.

mike2023

Buying from someone already committed to moving into a village is the dream at the moment, no one is prepared to meet the market more. Have seen it so many times in the last 12 months.

Cod

Volume profile shows a boat load of script crossing at $0.78, best case short term resolutions when price exits wedge beginning year 26 is 78c IMHO.
You cannot view this attachment.

850man

FY25 Result – Building on momentum

Oceania Healthcare (NZX: OCA) reported underlying EBITDA of $86.0m for the year ended 31 March 2025, up 4.1% on FY24, reflecting steady sales momentum and stock sell down. Building on this momentum, the company has signalled a sharpened strategy centred on strengthening its foundation, enhancing efficiency, and setting the stage for accelerating growth.

Financial summary and highlights

•Total comprehensive income of $74.6m (FY24: $70.5m).
•Reported NPAT of $30.4m (FY24: $31.5m).
•Underlying EBITDA rose to $86.0m, up 4.1% on FY24.
•Underlying NPAT was $52.5m, (15.5%) lower than FY24, a result of interest charges on completed developments no longer able to be capitalised.
•Operating cashflow increased to $110.3m, up 6.7% from FY24.
•Total assets increased to $2.9b, a $158m increase on FY24 largely a reflecting the completion of Elmwood, Waterford and Awatere alongside fair value movements due to the sell down of independent living units at other sites.
•Debt gearing reduced to 36.3%, down from FY24's 38.3%. All banking covenants were met.
•Realised capital gains rose to $83.2m, an increase of 22.6% on FY24.
•Premium care revenue was up 12.5% on FY24, reaching $25.4m.
•Total sales volume at The Helier increased 100% from FY24, with 24 apartments and care suites sold in FY25 and full development cost recovery expected by FY26.
•A broader business optimisation programme is underway, targeting $15m to $20m of cost savings with full benefits realised in FY27.

Steady sales momentum

Sales momentum accelerated in the second half of FY25, with new sales volumes increasing by 17.2% and resales up 5.3% on prior year, notwithstanding market conditions. This growth was driven by a revitalised sales and marketing approach, refined pricing strategies, and enhanced leadership in sales.

Strong sell down results were achieved across key development sites. Occupancy increased at The Helier in Auckland with 41% occupancy as at 20 May 2025 compared to 14% as at 31 March 2024. Additionally, Oceania successfully completed the full sell down of independent living apartments at The Bellevue in Christchurch shortly after year end, within just 24 months. The new care suite centre at Redwood in Blenheim has reached 62% occupancy in record time with expectations to be fully occupied within 12 months.

Financial performance

Total sales volumes were up 9.2% on the prior corresponding period (pcp), including a 17.2% uplift in new sales volumes to 184 independent living units (ILUs) and care suites.

Operating cash flow increased to $110.3 million, a 6.7% rise compared to $103.4m in FY24. This was driven by higher cash receipts from occupation right agreements, up 30.1% on pcp, reflecting key drivers such as improved settlement timing, reduced unsold stock, and increased care revenue.

Underlying NPAT was $52.5m for the 12 months ended 31 March 2025. This included total capital gains of $83.2m, an increase of $15.3m or 22.6% on the previous year.

Chair, Liz Coutts noted "As at 31 March 2025, undrawn net debt headroom was $97.0m and gearing reduced to 36.3%, down from 38.3% as at 31 March 2024. This improvement reflects continued capital discipline, divestment of non core assets, a sharpened sales focus and a targeted cost optimisation programme."

In March 2025, Oceania successfully refinanced its syndicated banking facilities, extending debt maturities and securing competitive terms with unchanged covenant conditions. The refinancing, supported by existing lenders ANZ, ASB, ICBC, and new lender BNZ, underscores lender confidence and positions Oceania for ongoing growth.

Final Dividend

Ms Coutts announced that "The Directors have resolved not to declare a final dividend. Work is underway to review our Dividend Policy so that it better aligns with the operating cashflows of the business. Our revised Dividend Policy will be announced at the time of the ASM in June."

Stabilising the core

In FY25, Oceania initiated an operational optimisation programme to realign the business and support its future strategy. This has already delivered $5m in cost savings, which will be realised in FY26.

Suzanne Dvorak, CEO said "We initiated a right sizing programme in FY25 to reshape the business and align with Oceania's future strategy. To date this programme has implemented cost savings of $5m that will be realised in FY26. Building on this, a broader business optimisation programme is underway, targeting $10m to $15m of sustainable annualised savings. So far in FY26, a further $5.2m of cost savings have been identified with benefits to be realised from 2HY26. Full benefits will be realised in FY27, with a focus on system consistency, margin discipline, and operational simplicity."

Over the next 12 months, Oceania will continue to sharpen execution, reinforce leadership capability, and ensure the business is well positioned to activate its new strategy from FY27.

Setting our strategic direction

The Board has approved a new strategic direction to guide Oceania through the next five years. Developed through deep engagement with the Board, executive team, employees, and independent consumer research with residents and families. It reflects both the lessons of the past and a clear vision for the future. Oceania's refreshed purpose — "Supporting and empowering people to live well as they age" — serves as the anchor for our next strategic phase. While grounded in Oceania's existing strengths, this is not a simple extension. It is a sharper and more ambitious plan, designed to meet changing resident expectations, increasing care needs, and a more complex operating environment.

Ms Dvorak added "Our strategy is structured around four refined focus areas — Connected Care, Inspired Living, Empowered People, and Purposeful Impact — the strategy will guide planning, investment, and operational decision making across the business."

This strategic direction positions Oceania to lead with clarity and confidence, supported by a strategy that is practical, measurable, focussed on creating value for our shareholders and is aligned with what matters most: people, purpose, and performance."

The full five year strategy will be further communicated in the coming months.

BlackPeter

Amazing. So many positive signals and than they end up with a still lower RoE and EPS than last year. Hmm.

So -
NTA up to $1.51/share. This must be good, isn't it?
avg Occupation up (though they seem to have changed the definition, its now occupation in units not impacted by development).
Resale and development margins improved - hey this must bring the earnings up - right? Oops, wrong!
Helier now occupied to 41% - give it another 2 to 3 years and they might approach Bau.
Gearing down (though only marginal)
Dividend unchanged (NIL)

but then:

RoE drops from a measly 3.1% to a mislier 2.8% and
EPS is now 4.2 cents per share (vs 4.3 cents).

Didn't they hit inflection point already a handful of years ago, and still building momentum? This must be a monumental swing ... give it another decade or so, and they might be in the money?

Basil

#1734
I agree with the tone of your post BP and note underlying profit hit a multi year low of $52.5m and on 723m shares that's just 7.26 cps.

They've averaged about 8 cps since they listed 8 years ago, I think the peak was close to 9 cps underlying one year they sold down a lot of the Sands development.

Blind Freddy can see there's no earnings growth here after 8 whole years.  When OCA listed they promised a full transformation program over the next 6 years that would transform the business model and deliver superior returns for shareholders.

We're now 8 years into that 6 year plan and there's no other way to describe it, the transformation program to date has been a epic failure in terms of delivering for shareholders.  Its clear all other stakeholders especially residents, the board, management and staff have enjoyed the transformation program and its delivered tangible results for all those stakeholders but nothing for shareholders who now languish without a dividend.

No worries, I am sure it will be much better in the future...that's what the zealot holders tell us every year...but I do note for the presentation a massive increase in aged stock over 12 months old, the unsold care suite legacy that simply won't go away that I have been talking about for years.  Looks like very modest progress in selling old unsold care suites.  CBRE think this is concerning to and marking them down but what would they know...

Fair value is no more than 8.5 times, (no growth PE and that's being generous as eps has been in decline) current year underlying eps of 7.26 cps = ~ 62 cents.

Others will listen to all the words from the current CEO and think going forward its going to be better.  I am sorry, I have literally lost count of how many years we've heard the corporate B.S. regurgitated in so many different ways.

I am tempted to think the current CEO may be on the right path with her efficiency drive but lets see the results of that before getting too excited eh. 

Poet

Quote from: Basil on May 22, 2025, 10:46 AMI agree with the tone of your post BP and note underlying profit hit a multi year low of $52.5m and on 723m shares that's just 7.26 cps.

They've averaged about 8 cps since they listed 8 years ago, I think the peak was close to 9 cps underlying one year they sold down a lot of the Sands development.

Blind Freddy can see there's no earnings growth here after 8 whole years.  When OCA listed they promised a full transformation program over the next 6 years that would transform the business model and deliver superior returns for shareholders.

We're now 8 years into that 6 year plan and there's no other way to describe it, the transformation program to date has been a epic failure in terms of delivering for shareholders.  Its clear all other stakeholders especially residents, the board, management and staff have enjoyed the transformation program and its delivered tangible results for all those stakeholders but nothing for shareholders who now languish without a dividend.

No worries, I am sure it will be much better in the future...that's what the zealot holders tell us every year...but I do note for the presentation a massive increase in aged stock over 12 months old, the unsold care suite legacy that simply won't go away that I have been talking about for years.  Looks like very modest progress in selling old unsold care suites.  CBRE think this is concerning to and marking them down but what would they know...

Fair value is no more than 8.5 times, (no growth PE and that's being generous as eps has been in decline) current year underlying eps of 7.26 cps = ~ 62 cents.

Others will listen to all the words from the current CEO and think going forward its going to be better.  I am sorry, I have literally lost count of how many years we've heard the corporate B.S. regurgitated in so many different ways.

I am tempted to think the current CEO may be on the right path with her efficiency drive but lets see the results of that before getting too excited eh. 

Basil/BP, do you see this poor performance as a management/board/governance issue? ie do you think it would perform better under new management/board/ownership. That's my view which is why I see this is probably presenting a good opportunity for takeover given the high value of underperforming assets (NTA=$1.51) vs market capitalisation.

A new owner might fancy their chances of increasing the ROE considerably and can buy at pennies on the $ right now

Basil

#1736
Quote from: Poet on May 22, 2025, 10:58 AMBasil/BP, do you see this poor performance as a management/board/governance issue? ie do you think it would perform better under new management/board/ownership. That's my view which is why I see this is probably presenting a good opportunity for takeover given the high value of underperforming assets (NTA=$1.51) vs market capitalisation.

A new owner might fancy their chances of increasing the ROE considerably and can buy at pennies on the $ right now

Hi Poet,

I think the new CEO is on the right path with a major cost out exercise.  If she can get the ~$20m per annum efficiencies she's looking for and they can get on top of their problems with vast numbers of old stock of unsold care suites the company becomes more investable.

Please note that the adjusted NTA is $1.43, (CBRE have marked down the value of the problematic old stock considerably).

Systemic legacy issues remain of grossly inadequate return on assets in the care sector, due to successive governments egregiously underfunding the true cost of care.  They've now sold 18 of the original facilities they listed with at the IPO which is a sad indictment on the lack of quality that private equity brought to market, so they are making progress but there's a LOT of work to do.

In terms of takeover prospects its worth noting that both ARV and MET had a substantially more efficient business model which a much lower level of care in their business models.

ARV being the most recent takeover target was taken over within a couple of cents of embedded value and I think that's the best proxy for any possible takeover level, if it ever eventuates and the risk here is the care side of the operations provides such egregiously low returns on equity, OCA is almost bullet proof to takeover, other than at a deeply discounted level by some party looking to extract head office and operational synergies.

Embedded value stood at $591m up 14% YOY equivalent to 82 cps.  I'd be very surprised if anyone would pay anything much more than that and even more surprised if that was sufficient to execute the deal.

For me, its well worth remembering that potential acquirers have had the opportunity to take this over for many years now and passed it over first in favour of MET and then in favour of ARV.

On the other hand, you could argue that every dog has its day and the strategic direction of the company could generate improved returns in the years ahead and some acquirer might take that view too.

Good luck with it Poet.  For me, I like the chances of a much improved takeover for MCK a LOT more than I do for the chances of this being taken over.    Aside from that, $4.70 / $2.80 for MCK is a much better prospect for percentage gains than say 85 cents / 65 cents.  That and CDL already own 84% of the shares and 91% of the preference shares.  My motto is one takeover play at a time as that keeps things simple in my head lol

BlackPeter

#1737
Quote from: Poet on May 22, 2025, 10:58 AMBasil/BP, do you see this poor performance as a management/board/governance issue? ie do you think it would perform better under new management/board/ownership. That's my view which is why I see this is probably presenting a good opportunity for takeover given the high value of underperforming assets (NTA=$1.51) vs market capitalisation.

A new owner might fancy their chances of increasing the ROE considerably and can buy at pennies on the $ right now

Interesting question.

While I haven't done as much groundwork research as some others on the other channel, I have seen some of their local villages and think that the substance of the new builds is in good shape. And clearly, there is demand for their services. Some of their premises however seem to mismatch market demand (like the Helier).

So - yes, they clearly made mistakes in the past, and some are easier to fix than others. It feels they wasted some of their original advantages of starting  with crappy sites in great locations by building too high density buildings on these sites instead of staying with NZ's love for stand alone villas. Having said that, I am sure that there is value for somebody who knows how to run an enterprise like that to turn it around.

As beagle already stated, the latest CEO is still new ... and at this stage it feels she is moving in the right direction. Will she succeed? Time will tell.

Other retirement providers (though admittedly with a different mix of villas vs care suits) seem to be able to achieve a better RoE. No, not Ryman (they are still more pathetic at 0.1%), but SUM had in FY24 already an RoE of 11.4%.   

So - I assume they will improve even under the current CEO (but its hard to make at this stage a case for best of breed), and a new owner well might be able to turn the ship somewhat faster around. How much they would be prepared to pay for it at current? Not sure, but given that residential real estate is still at the cyclical bottom (and might stay there for some time to come) I agree with beagle, that the takeover premium probably won't be outrageous.

Shareguy

Craig's thoughts

OCA has reported a FY25 result in line with consensus, but FCF remains stubbornly negative (net debt increased in 2H25) which we see as incrementally disappointing. With little outlook commentary, there is not much to get excited about here. uEBITDA increased 4% YoY to $86m, but uNPAT fell 15%, both in-line with consensus. uNPAT declined as (i) net debt and gross interest expense increased and (ii) interest expense recognised in the P&L increased $10m YoY following completion of key developments (meaning the interest can no longer be capitalised).

Basil

Biggest impediment to the remote chance of any possible future takeover attempt is an intransigent board putting their own interests first and dismissing any approach without even bringing it to shareholders attention for a vote on the basis that it's below their assessment of fair intrinsic value. Recall how the board of ARV dismissed the first approach at $1.70 out of hand and it only came to the public's attention after one of the institutional shareholders who was consulted leaked it to the media.
Another good example Steel and Tube board rejecting FBU's bid at $1.90. Look how that worked out for shareholders.

As Craig's say. Nothing to get excited about here with this company that burns through cash in a stubbornly depressing way